Alex Marchut

Alex Marchut has a diverse work experience in the pharmaceutical industry. They have worked as a Director of Technical Operations API at Mineralys Therapeutics, Inc. since 2023. Prior to that, they served as an Associate Director at Wellstat Therapeutics Corporation, where they were responsible for Chemistry, Manufacturing, and Controls (CMC) projects, regulatory affairs support, and data science. Before that, they held the position of Associate Director at Esperion - The Lipid Management Company.

Alex also has experience at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Principal Scientist, where they focused on modeling and simulation to support scale-up and technology transfer of drug substance and drug product. They also worked as a Principal Research Engineer at Prochem Solutions Pte Ltd, leading projects related to API formulation and drug delivery.

Earlier in their career, Alex worked at Abbott Laboratories as a Senior Scientist II, handling the scale-up of organic synthesis of pharmaceutical compounds. They also had a role as a Research Investigator at Bristol-Myers Squibb, where they worked on modeling pharmaceutical process engineering phenomena and scale-up of organic synthesis.

Overall, Alex Marchut has extensive experience in technical and leadership roles within the pharmaceutical industry.

Alex Marchut's education history includes a Bachelor of Science in Chemical Engineering from the University of Pennsylvania and a PhD in Chemical Engineering from North Carolina State University. However, the exact years of completion for these degrees are not provided.